BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21871156)

  • 21. Fluoxetine pretreatment effects pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA, ECSTASY) in rat.
    Upreti VV; Eddington ND
    J Pharm Sci; 2008 Apr; 97(4):1593-605. PubMed ID: 17724664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.
    Chu T; Kumagai Y; DiStefano EW; Cho AK
    Biochem Pharmacol; 1996 Mar; 51(6):789-96. PubMed ID: 8602874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans.
    Mueller M; Kolbrich EA; Peters FT; Maurer HH; McCann UD; Huestis MA; Ricaurte GA
    Ther Drug Monit; 2009 Jun; 31(3):367-73. PubMed ID: 19417716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) stereoisomers in a fatal poisoning.
    Moore KA; Mozayani A; Fierro MF; Poklis A
    Forensic Sci Int; 1996 Dec; 83(2):111-9. PubMed ID: 9022274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population pharmacokinetics of 3,4-methylenedioxymethamphetamine and main metabolites in rats.
    Hirt D; Fonsart J; Menet MC; Debray M; Noble F; Declèves X; Scherrmann JM
    Toxicol Sci; 2010 Mar; 114(1):38-47. PubMed ID: 20008456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of an LC-MS/MS method after chiral derivatization for the simultaneous stereoselective determination of methylenedioxy-methamphetamine (MDMA) and its phase I and II metabolites in human blood plasma.
    Steuer AE; Schmidhauser C; Liechti ME; Kraemer T
    Drug Test Anal; 2015 Jul; 7(7):592-602. PubMed ID: 25371386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine transporter down-regulation following repeated cocaine: implications for 3,4-methylenedioxymethamphetamine-induced acute effects and long-term neurotoxicity in mice.
    Peraile I; Torres E; Mayado A; Izco M; Lopez-Jimenez A; Lopez-Moreno JA; Colado MI; O'Shea E
    Br J Pharmacol; 2010 Jan; 159(1):201-11. PubMed ID: 20015297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain concentrations of d-MDMA are increased after stress.
    Johnson EA; O'Callaghan JP; Miller DB
    Psychopharmacology (Berl); 2004 May; 173(3-4):278-86. PubMed ID: 14735292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH.
    Navarro M; Pichini S; Farré M; Ortuño J; Roset PN; Segura J; de la Torre R
    Clin Chem; 2001 Oct; 47(10):1788-95. PubMed ID: 11568088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration.
    Barnes AJ; Scheidweiler KB; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA
    Ther Drug Monit; 2011 Oct; 33(5):602-8. PubMed ID: 21860342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enantioselective metabolism of the designer drugs 3,4-methylenedioxymethamphetamine ('ecstasy') and 3,4-methylenedioxyethylamphetamine ('eve') isomers in rat brain and blood.
    Meyer A; Mayerhofer A; Kovar KA; Schmidt WJ
    Neurosci Lett; 2002 Sep; 330(2):193-7. PubMed ID: 12231444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans.
    Fallon JK; Kicman AT; Henry JA; Milligan PJ; Cowan DA; Hutt AJ
    Clin Chem; 1999 Jul; 45(7):1058-69. PubMed ID: 10388483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
    de la Torre R; Farré M; Ortuño J; Mas M; Brenneisen R; Roset PN; Segura J; Camí J
    Br J Clin Pharmacol; 2000 Feb; 49(2):104-9. PubMed ID: 10671903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of 3,4-methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection.
    Ortuño J; Pizarro N; Farré M; Mas M; Segura J; Camí J; Brenneisen R; de la Torre R
    J Chromatogr B Biomed Sci Appl; 1999 Feb; 723(1-2):221-32. PubMed ID: 10080649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of caffeine on MDMA-induced hydroxyl radical production in the mouse striatum.
    Górska AM; Noworyta-Sokołowska K; Gołembiowska K
    Pharmacol Rep; 2014 Aug; 66(4):718-21. PubMed ID: 24948078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration.
    Schwaninger AE; Meyer MR; Barnes AJ; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA; Maurer HH
    Clin Chem; 2011 Dec; 57(12):1748-56. PubMed ID: 21980168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
    Colado MI; Williams JL; Green AR
    Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.
    Mueller M; Goodwin AK; Ator NA; McCann UD; Ricaurte GA
    J Pharmacol Exp Ther; 2011 Jul; 338(1):310-7. PubMed ID: 21493752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral fluid and plasma 3,4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration.
    Desrosiers NA; Barnes AJ; Hartman RL; Scheidweiler KB; Kolbrich-Spargo EA; Gorelick DA; Goodwin RS; Huestis MA
    Anal Bioanal Chem; 2013 May; 405(12):4067-76. PubMed ID: 23471370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.